Clinical Trials Logo

Clinical Trial Summary

Reintroduction of small doses of food in allergic children to lightening the elimination diet.


Clinical Trial Description

In four groups of allergic children (peanuts, wheat , milk and egg), a reintroduction of 4 small increasing doses of allergen is carried out progressively double-blind placebo- cons , randomized, during a hospitalization.

The procedure for reintroduction of small doses (MPD) is stopped at the appearance of intolerance (in taking a dose of allergen or placebo) defined by the onset of allergic symptoms or objective severe abdominal pain within 45 minutes of taking. ;


Study Design

Intervention Model: Single Group Assignment, Masking: Open Label


Related Conditions & MeSH terms


NCT number NCT02384707
Study type Interventional
Source University Hospital, Angers
Contact Martine Drouet
Email madrouet@chu-angers.fr
Status Recruiting
Phase N/A
Start date May 2011
Completion date December 2015

See also
  Status Clinical Trial Phase
Withdrawn NCT02286999 - Probiotic Supplementation in Breastfed Newborn Infants Phase 1
Terminated NCT00736281 - Sublingual Immunotherapy for Food Allergy N/A
Completed NCT00247156 - An Autism Study Using Nambudripad's Food Allergy Elimination Treatments Phase 1/Phase 2
Completed NCT01631591 - Prevalence of Food Allergies in a Cohort of Adult Patients With Eosinophilic Esophagitis
Active, not recruiting NCT02208414 - Randomized Double-Blind Placebo-Controlled Crab or Shrimp Allergy Reduction Study Using Nambudripad Allergy Elimination Techniques N/A
Terminated NCT01577628 - Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis N/A
Completed NCT00277407 - Treatment of Autistic Children Using NAET Procedures N/A